Investors Hangout Stock Message Boards Logo
  • Mailbox
  • Favorites
  • Boards
    • The Hangout
    • NASDAQ
    • NYSE
    • OTC Markets
    • All Boards
  • Whats Hot!
    • Recent Activity
    • Most Viewed Boards
    • Most Viewed Posts
    • Most Posted
    • Most Followed
    • Top Boards
    • Newest Boards
    • Newest Members
  • Blog
    • Recent Blog Posts
    • Recently Updated
    • News
    • Stocks
    • Crypto
    • Investing
    • Business
    • Markets
    • Economy
    • Real Estate
    • Personal Finance
  • Market Movers
  • Interactive Charts
  • Login - Join Now FREE!
  1. Home ›
  2. Stock Message Boards ›
  3. Stock Boards ›
  4. ADiTx Therapeutics Inc. (ADTX) Message Board

Study Highlights New Insights on Neurological Auto

Message Board Public Reply | Private Reply | Keep | Replies (0)                   Post New Msg
Edit Msg () | Previous | Next


Post# of 112
(Total Views: 226)
Posted On: 07/19/2022 5:29:17 PM
Avatar
Posted By: NetworkNewsWire
Study Highlights New Insights on Neurological Autoimmune Illnesses

UT Southwestern researchers recently reported that they had used cryoelectron microscopy to obtain the image of an auto-antibody that had bound itself to the surface receptor of a nerve cell. This discovery shows the mechanism behind neurological autoimmune illnesses and may be useful in the development of novel therapies for autoimmune diseases.

Autoimmune illnesses are disorders that cause an individual’s immune system to mistakenly attack their body. These illnesses reduce the body’s ability to fight germs such as viruses and bacteria, which in turn, makes individuals susceptible to infections. Common autoimmune illnesses include systemic lupus erythematosus, rheumatoid arthritis, multiple sclerosis, inflammatory bowel disease, psoriasis and type 1 diabetes.

The study, which was led by Ryan Hibbs and Colleen M. Noviello, was conducted after investigators in Germany identified an eight-year old patient with autoimmune encephalitis, which they believe was caused by antibodies attacking the γ-aminobutyric acid type A receptor (GABAA receptor). Autoimmune encephalitis is an inflammation in the brain that causes a person’s immune system to attack healthy tissues and cells in the spinal cord or brain.

Hibbs has specialized in biophysics and neuroscience and is a scientist at Charité – Universitätsmedizin Berlin, in the Harald Prüss lab; he is also a researcher in the Peter O’Donnell Jr. Brain Institute and an Effie Marie Cain scholar in medical research.

The researchers confirmed that two types of antibodies obtained from the immune cells of the patient bound to this particular receptor. Once this was done, the scientists, in collaboration with their partners in the Hibbs laboratory, carried out cryoelectron microscopy. The cryoelectron microscopy facility at UT Southwestern was launched about six years ago and offers three-dimensional images of biomacromolecules.

In their report, the researchers stated that autoantibodies that targeted neuronal membrane proteins caused seizures, encephalitis and acute behavioral abnormalities. They explained that while antibodies for a number of neuronal targets had been identified, scientists were in the dark on how they regulated function, until now.

Assistant professor of neuroscience at UT Southwestern, Noviello, who has specialized in capturing cryoelectron microscopy images up to atomic resolution, added that their findings ushered in a new era of understanding how autoimmune illnesses worked in the central nervous system. In their conclusion, they noted that they were now focused on identifying residues in the antibodies involved in affinity and specificity

The researchers and collaborators reported their findings in the “Cell” journal. They plan to partner with their colleagues to study more autoimmune illnesses that affect the human central nervous system.

Companies such as Aditxt Inc. (NASDAQ: ADTX) are also looking into mechanisms through which the immune system can be retrained so that autoimmune illnesses can be halted in their progression or even reversed so that patients can enjoy a better quality of life.

NOTE TO INVESTORS: The latest news and updates relating to Aditxt Inc. (NASDAQ: ADTX) are available in the company’s newsroom at https://ibn.fm/ADTX

Please see full terms of use and disclaimers on the BioMedWire website applicable to all content provided by BMW, wherever published or re-published: http://BMW.fm/Disclaimer




(0)
(0)




ADiTx Therapeutics Inc. (ADTX) Stock Research Links


  1.  
  2.  


  3.  
  4.  
  5.  






Investors Hangout

Home

Mailbox

Message Boards

Favorites

Whats Hot

Blog

Settings

Privacy Policy

Terms and Conditions

Disclaimer

Contact Us

Whats Hot

Recent Activity

Most Viewed Boards

Most Viewed Posts

Most Posted Boards

Most Followed

Top Boards

Newest Boards

Newest Members

Investors Hangout Message Boards

Welcome To Investors Hangout

Stock Message Boards

American Stock Exchange (AMEX)

NASDAQ Stock Exchange (NASDAQ)

New York Stock Exchange (NYSE)

Penny Stocks - (OTC)

User Boards

The Hangout

Private

Global Markets

Australian Securities Exchange (ASX)

Euronext Amsterdam (AMS)

Euronext Brussels (BRU)

Euronext Lisbon (LIS)

Euronext Paris (PAR)

Foreign Exchange (FOREX)

Hong Kong Stock Exchange (HKEX)

London Stock Exchange (LSE)

Milan Stock Exchange (MLSE)

New Zealand Exchange (NZX)

Singapore Stock Exchange (SGX)

Toronto Stock Exchange (TSX)

Contact Investors Hangout

Email Us

Follow Investors Hangout

Twitter

YouTube

Facebook

Market Data powered by QuoteMedia. Copyright © 2025. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges).
Analyst Ratings & Earnings by Zacks. RT=Real-Time, EOD=End of Day, PD=Previous Day. Terms of Use.

© 2025 Copyright Investors Hangout, LLC All Rights Reserved.

Privacy Policy |Do Not Sell My Information | Terms & Conditions | Disclaimer | Help | Contact Us